Abstract Freezing is the most common method for storing bones until use in skeletal reconstruction. However, the effect of freezing on antibiotic delivery from antibiotic-coated bone has not been evaluated. In this study, we compared antibiotic delivery in vitro from gentamicin-coated human bone stored at different temperatures. Bone chips obtained from human femur heads were chemically cleaned and mixed with gentamicin sulfate. Samples were stored for 4 months at -20°C, 4 months at -80°C, or evaluated immediately without freezing. Antibiotic release from the bone chips was measured using Bacillus subtilis as an indicator strain. Zones of inhibition and rates of gentamicin release were similar in all three groups. Storage at -20 and -80°C for bone allografts has no effect on gentamicin release from chemically cleaned bone chips.
Introduction
Bone grafting is indicated for joint reconstruction, repair of congenital skeletal defects and reconstruction of bone tissue after trauma and disease (Hinsenkamp et al. 2012; Putzer et al. 2011) . Bone grafting can be carried out using autografts (tissue from the same patient) or allografts (tissue from the same species). Bone allografts avoid problems of autografts, including donor site morbidity and availability (Barbour and King 2003; Butler et al. 2005; Haimi et al. 2008 ). However, allografts are immunogenic (Stevenson and Horowitz 1992) and can transmit infectious diseases (Chapman and Villar 1992) . To eliminate these problems and make human bone tissue suitable for transplantation, bone banks routinely decontaminate bone samples by mechanical and chemical cleaning and by freeze-drying (Lomas et al. 2000; Scarborough 1992; Holzmann et al. 2010) . Also, infections can occur at the surgical site of contaminated bone grafts, leading to biofilm formation (Coraça-Hubér et al. 2012) . Such biofilms can be difficult to treat after surgery involving impaction because the impaction creates an avascular area where local circulation is disrupted, limiting the ability of systemically administered antibiotics to reach the infected bone (Isefuku et al. 2003) .
Bone cements containing antibiotics were developed to prevent and treat implant-related infections. However, the efficacy of the antibiotic-loaded cements is uncertain. Most of the antibiotics contained in the cements are never released. Only when cracks are formed in the cement layer will a small, sub-inhibitory amount of antibiotic be released into the surrounding tissue. This release can continue for years, potentially inducing bacterial resistance (van de Belt et al. 2001; Winkler et al. 2006) . Also, infections can be prevented by coating or impregnating morselized human bone with an antibiotic solution (Witsø et al. 2005; Winkler et al. 2000) or by combining it with antibiotic powders (Buttaro et al. 2003 (Buttaro et al. , 2005 . Clinical studies using antibiotic-coated bone grafts have been performed with positive results (Winkler 2009; Borkhuu et al. 2008) . Winkler et al. (2008) reported the use of allografts mixed with vancomycin and tobramycin in 37 one-stage revisions of infected total hip replacements. Nearly all (92 %) of the operated hips remained free from infection and stable at a mean follow-up of 4.4 years (Winkler et al. 2008) .
Freezing is the most common method for storing bone to be used in skeletal reconstructions. Bone banks protocols suggest that bone must be kept at low temperatures for more than 90 days and that it can be stored up to five years (Farrington et al. 1998) . However, the effect of cryopreservation on gentamicin release is unknown. In this study, we quantitatively compared the release of gentamicin from coated human bone chips (BCh) after different storage temperatures.
Materials and methods

Preparation of BCh
Femur heads were obtained from the bone bank of the Medical University Innsbruck, Austria. The femur heads were obtained during femoral head osteotomy from patients who had undergone hip replacement surgery at the Medical University of Innsbruck. Throughout the procedure, the bone was rinsed and cooled with sterile 0.9 % saline to prevent damage. Cortical and cartilage tissues were removed from the femoral heads with a bone saw. BCh (5-10 mm diameter) were prepared from the spongious tissue using a bone mill (Noviomagus Bone Mill, Spierings Medische Techniek BV, Nijmegen, The Netherlands). BCh were mixed to achieve homogenous bone quality. All patients previously approved the use of the specimens for research purposes.
Chemical cleaning, storage, and gentamicin coating of samples BCh were cleaned by chemical method based on a procedure described by DePaula and collaborators (DePaula et al. 2005) . BCh (1 g) were placed in polypropylene centrifuge tubes and sonicated using an ultrasonic bath (Bandelin electronic GmbH & Co. KG, Berlin, Germany) in the following series of solutions ( Fig. 1 ): (i) 3 ml of 1 % Triton X-100 (Sigma-Aldrich, Schnelldorf, Germany) for 30 min at 45-50°C, (ii) 3 ml of sterile distilled water for 5 min at 45-50°C, (iii) 3 ml sterile distilled water for 10 min at 40-45°C, (iv) 14 ml of 3 % hydrogen peroxide (Sigma-Aldrich, Schnelldorf, Germany) for 60 min at room temperature, (v) 3 ml sterile distilled water for 5 min at room temperature, (v) 3 ml sterile distilled water for 5 min at room temperature, (vi) 3 ml sterile distilled water for 30 min at room temperature, (vii) 3 ml of 70 % ethanol for 60 min at room temperature, (viii) 3 ml sterile distilled water for 10 min at room temperature, and (ix) 3 ml sterile distilled water for 30 min at room temperature. Finally, the water was removed and the samples stored in a refrigerator at 3-4°C. Each 1-g sample of BCh was mechanically mixed with 8 mg of gentamicin sulfate powder (equivalent to 5 mg of gentamicin basis; SERVA GmbH, Heidelberg, Germany) using a sterile spatula. Samples were stored for 4 months at -20°C (n = 5), 4 months at -80°C (n = 5), or examined immediately (control; n = 5).
Measurement of gentamicin release from BCh
Frozen samples were thawed at room temperature for 1 h and then mixed with 3 ml of phosphate-buffered saline (PBS) pH 7.4 (Sigma-Aldrich, Schnelldorf, Germany). Samples were vortexed for 1 min and placed on a rocking table (Rocky Ò Biometra, Goettingen, Germany) at 37°C. Every day for 1 week, the solutions were transferred to a centrifuge tube and replaced with 3 ml fresh PBS. Collected elutions were vortexed and frozen at -20°C.
After 1 week, antibiotic concentrations in the elutions were determined with a conventional microbiological agar diffusion assay using Bacillus subtilis (Merck KGaA, Germany in Test Agar pH 8.0 Merck KGaA, Germany) as the indicator strain (Stevens et al. 2005 ). Using a 6-mm diameter metal punch, a hole was made at the centre of each B. subtilis agar plate into which 50 ll of each elution or 50 ll of 10-fold dilutions (from 10.000 to 0.01 mg/l) of gentamicin sulfate (standard curve) were added. The plates containing the samples were incubated for 24 h at 37°C. After the incubation period, the diameter of the zones of inhibition in cm was measured from each plate using a ruler. The diameter was confirmed with a second measurement. This method was carried out in triplicate. The standard curve was obtained by logarithmic regression and used to predict the concentration of gentamicin in each elution.
Statistical analysis
One-way analysis of variance was used to analyse the differences between the release rates of gentamicin. Sheffe and Games-Howel post hoc analysis were used to confirm differences in all cases. P values B0.05 were considered statistically significant. SPSS 17.0 (IBM, Chicago, Illinois) was used for the statistical analysis. 
Results
Zone of inhibition measured with B. subtilis bioassay
Zones of inhibition measured from the B. subtilis bioassay showing similar diameter for all storage conditions (-20°C, -80°C and control; Fig. 2) . Overall, the mean zone of inhibition was 4.1 cm on day 1 and decreased to mean of 3.0 cm on day 7.
Effect of storage conditions on gentamicin release rate
The concentration of gentamicin sulfate released from samples stored at -20°C was 823 ± 266 mg/l (mean ± SD) on day 1 and 270 ± 71 mg/l on day 2 (Fig. 3) . Release of gentamicin from samples stored at -80°C was 1,214 ± 708 mg/l day 1 and decreased to 210 ± 45 mg/l on day 2. Release from the control group was similar for the samples stored at -20°C. On day 7, the release from the samples stored at -20 and -80°C were similar, with a mean of 19 ± 7 mg/l. Overall, the release of gentamicin decreased gradually over time at a similar rate in all groups. The rate of gentamicin delivery did not differ between the groups (P = 0.49 by one-way analysis of variance).
Discussion and conclusions
This study quantitatively compared antibiotic release from gentamicin-coated BCh after storage at -20, and -80°C, and non-stored samples. We found that the release of antibiotic from gentamicin-coated BCh was similar between the groups. In this study, the BCh were cleaned with hydrogen peroxide followed by ethanol and biological detergent baths for fat removal. However, because infection remains a concern, coating bone grafts with antibiotic powder or its impregnating in antibiotic solution has been considered (Winkler et al. 2000 (Winkler et al. , 2006 . In this study, to coat the bone grafts, we manually mix them with the gentamicin powder. This is a relatively easy procedure that could be suitable for an operating room. Also, antibiotic coating can be carried out prior the cryopreservation in bone banks. Some authors first dilute the antibiotic powder in saline solution and then soak the bone grafts in this solution, storing them for weeks or months before use (Witsø et al. 2005; Winkler et al. 2000) . We believe that this is an efficient method for BCh impregnation. However, Sorger et al. (2001) suggested that preserving the grafts for up to 100 h in an antibiotic solution might compromise the mechanical stability of the bone. Based on Parrish (1973) and Witsø et al. (2005) , allografts impregnated with antibiotics in solution should be tested for mechanical and structural characteristics before clinical use.
Antibiotic-impregnated or coated cancellous bone might be an alternative or supplement to bone cements. Fig. 2 Zone of inhibition. BCh were treated as described in Fig. 1 . Gentamicin released from the BCh was measured by using a B. subtilis bioassay. Symbols indicate the mean diameter of the zone of inhibition. Error bars represent the standard deviation Antibiotic-coated BCh can be used in revisions of aseptic and septic loosened hip and knee prostheses. In a clinical study of two-stage revision arthroplasties, the reinfection rate was lower using bone allografts impregnated with antibiotics than using grafts without antibiotics (Buttaro et al. 2005) . Antibiotic-containing allografts can also be used for non-healed fractures and, in particular, for infected pseudoarthroses (Witsø et al. 2005) . The frequency of antibiotic resistance after using antibiotic-impregnated bone allografts remains to be determined. Also, the deleterious effect of gentamicin on osteogenesis in antibiotic-coated or impregnated cancellous bone needs to be clarified. According to Isefuku (2003) , gentamicin, at high concentrations, as achieved following topical application, inhibits cell proliferation in vitro and, therefore, may be detrimental to the repair process in vivo.
In conclusion, we found that storage at -20 and -80°C has no effect on gentamicin release from chemically cleaned BCh. Therefore, our results suggest that BCh can be coated with antibiotics prior to short-term cryopreservation of human bone allografts. Further studies on long-term storage are necessary to recommend this practice to bone banks.
